SYNDAX PHARMACEUTICALS INC
SNDXNASDAQ🏆 #2155 by market capEarnings Oct 29US Equity
$18.24▲ $0.38 (+2.10%)
🌙 After hours$18.75▲ 2.82%Regular close · extended-hours price shownTrack SNDX
Get earnings, price moves & breaking news on Telegram
24h▲ 2.1%
7d▲ 3.3%
14d▲ 5.6%
30d▼ 5.5%
ytd▼ 13.2%
1y▲ 18.5%
🏦Market Cap
$1.62B
Small Cap
📈Revenue Growth (YoY)
+627.8%
High Growth
📊Gross Margin
97.5%
High
💵FCF Margin
-87.6%
Thin
⚖️P/S Ratio
6.4x
Fair
Otter Score
60
Fair
SYNDAX PHARMACEUTICALS INC
SNDXAnalyst Ratings
Price
$18.24
Total
22
Raised
0
Lowered
0
Avg PT
$36.67
H / L
$46 / $31
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
UBS | Reiterated | Buy | 2026-08-21 | $33.00 | +81.00% |
JP Morgan | Reiterated | Overweight | 2026-08-11 | $41.00 | +124.80% |
HC Wainwright & Co. | Reiterated | Buy | 2026-08-05 | — | — |
Barclays | Reiterated | Overweight | 2026-05-01 | $37.00 | +102.90% |
Goldman Sachs | Reiterated | Buy | 2026-04-01 | $18.00 | −1.30% |
Mizuho | Reiterated | Outperform | 2026-03-31 | — | — |
Citigroup | Reiterated | Buy | 2026-03-02 | $34.00 | +86.50% |
BTIG | Reiterated | Buy | 2025-12-09 | — | — |
Guggenheim | Reiterated | Buy | 2025-05-06 | $31.00 | +70.00% |
Scotiabank | Reiterated | Sector Perform | 2025-05-06 | $18.00 | −1.30% |
Stifel | Reiterated | Buy | 2024-10-14 | — | — |
B of A Securities | Reiterated | Buy | 2024-08-15 | — | — |
B. Riley Securities | Reiterated | Buy | 2023-07-25 | — | — |
Morgan Stanley | Reiterated | Equal Weight | 2021-10-12 | — | — |
H.C. Wainwright | Reiterated | Buy | 2020-05-11 | $38.00 | +108.40% |
Baird | Reiterated | Outperform | 2020-03-04 | — | — |
Nomura | Reiterated | Buy | 2018-12-17 | — | — |
B. Riley FBR | Reiterated | Buy | 2018-01-05 | — | — |
Cowen & Co. | Reiterated | Outperform | 2017-03-24 | — | — |
FBR Capital | Reiterated | Outperform | 2017-03-16 | — | — |
Oppenheimer | Reiterated | Outperform | 2016-03-31 | — | — |
JMP Securities | Reiterated | Market Outperform → Outperform | 2016-03-28 | — | — |
Institution
UBS
Reiterated · Buy · 2026-08-21
$33.00
+81.00%
JP Morgan
Reiterated · Overweight · 2026-08-11
$41.00
+124.80%
HC Wainwright & Co.
Reiterated · Buy · 2026-08-05
—
—
Barclays
Reiterated · Overweight · 2026-05-01
$37.00
+102.90%
Goldman Sachs
Reiterated · Buy · 2026-04-01
$18.00
−1.30%
Mizuho
Reiterated · Outperform · 2026-03-31
—
—
Citigroup
Reiterated · Buy · 2026-03-02
$34.00
+86.50%
BTIG
Reiterated · Buy · 2025-12-09
—
—
Guggenheim
Reiterated · Buy · 2025-05-06
$31.00
+70.00%
Scotiabank
Reiterated · Sector Perform · 2025-05-06
$18.00
−1.30%
Stifel
Reiterated · Buy · 2024-10-14
—
—
B of A Securities
Reiterated · Buy · 2024-08-15
—
—
B. Riley Securities
Reiterated · Buy · 2023-07-25
—
—
Morgan Stanley
Reiterated · Equal Weight · 2021-10-12
—
—
H.C. Wainwright
Reiterated · Buy · 2020-05-11
$38.00
+108.40%
Baird
Reiterated · Outperform · 2020-03-04
—
—
Nomura
Reiterated · Buy · 2018-12-17
—
—
B. Riley FBR
Reiterated · Buy · 2018-01-05
—
—
Cowen & Co.
Reiterated · Outperform · 2017-03-24
—
—
FBR Capital
Reiterated · Outperform · 2017-03-16
—
—
Oppenheimer
Reiterated · Outperform · 2016-03-31
—
—
JMP Securities
Reiterated · Market Outperform → Outperform · 2016-03-28
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space